Can perimenopausal hormone fluctuations alter stress and mood reactivity?

Perimenopause involves variable, rather than uniformly declining, estradiol levels and increasingly unreliable ovulation/progesterone production. This hormonal instability is associated with altered stress physiology and greater vulnerability to negative mood, although effects differ substantially among individuals.

Clinical and stress-physiology evidence

• Longitudinal evidence links greater baseline estradiol fluctuation with a larger cortisol area-under-the-curve response to the Trier Social Stress Test, indicating altered acute HPA-axis stress regulation.
• A 12-week study of 101 perimenopausal women found that greater average vasomotor-symptom burden was associated with a blunted cortisol-awakening response, independent of urinary estradiol and progesterone metabolites. Thus, HPA-axis changes may also track the symptomatic consequences of the transition, not hormone measures alone.
• Findings are not uniform across cortisol outcomes: estradiol-metabolite variability predicted cardiovascular and emotional stress responses in one repeated-measures study but not salivary cortisol.

Mood and stress reactivity

• Intensive prospective sampling found that greater estradiol variability predicted higher negative affect, anhedonia, and depressive symptoms. Week-to-week estradiol increases tracked sadness, anger, anxiety, guilt, hopelessness, and rejection-related symptoms.
• Larger estradiol fluctuations during stress testing have also been associated with greater negative affect and physiological stress responses in susceptible women, particularly those with current or previous depression.
• This pattern is not a universal explanation for symptoms: irritability was associated with lower estradiol variability in one repeated-measures study, and weekly estradiol change did not predict irritability.

Mechanistic interpretation

• Estradiol may modify corticotropin-releasing hormone signaling and glucocorticoid feedback, influencing cortisol reactivity and recovery.
• Rapid changes in progesterone-derived allopregnanolone could affect GABA-A receptor plasticity and inhibitory regulation of stress circuits; this remains biologically plausible rather than directly proven in endogenous perimenopausal hormone fluctuations.

Bottom line

• The claim is supported with moderate confidence, strongest for estradiol variability in relation to cortisol stress responses and negative mood. Progesterone-specific effects, ACTH changes, and effects in every perimenopausal woman are less firmly established.